The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts
Among lean tissues, loss of liver mass exceeds change in muscle mass
CMS Extends Medicares Short-Term Bridge Program for GLP-1 Obesity Drug Coverage The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on January 1, 2027
Hair Growth & Scalp Care Shop GHK-Cu shampoo, conditioner, serum and scalp care products
You may like this article: How To Use Oatmeal Baths For Soothing Itchy Skin That said, steroid creams are not a long-term solution for preventing eczema or addressing the root causes of flare-ups
Heart rate may increase